Insight Molecular Diagnostics Inc. Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
Insight Molecular Diagnostics Inc. (IMDX) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of 0.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-19.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2021-03-19
- Insight Molecular Diagnostics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2020 was 0.00%.
- Insight Molecular Diagnostics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2019 was 0.00%.
- Insight Molecular Diagnostics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2018 was -1.00%.
- Insight Molecular Diagnostics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2017 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month |
|---|---|
| 2020-12-31 | 0.00% 10-K · filed 2021-03-19 |
| 2019-12-31 | 0.00% 10-K · filed 2021-03-19 |
| 2018-12-31 | -1.00% 10-K · filed 2020-03-26 |
| 2017-12-31 | 0.00% 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |